This protein dephosphorylation method uses a two-step approach to focus on specificity and potency. The first treatment is done with a lambda phosphatase to specifically target phosphate groups from threonine, serine, and tyrosine amino acids for dephosphorylation. Most phosphatases only dephosphorylate serine and threonine amino acids. If you are testing the phosphospecificity of a tyrosine phosphospecific antibody, lambda phosphatase is essential. The second dephosphorylation treatment is done with an alkaline phosphatase, a significantly more potent enzyme than lambda phosphatase. The alkaline phosphatase only dephosphorylates phosphate groups from threonine and serine amino acids, and therefore is not intended to be utilized alone to determine the phosphospecificity of tyrosine phosphospecific antibodies. When using both lambda and alkaline phosphatases in conjunction with each other, it is best to separate the treatments so the alkaline phosphatase doesn’t inhibit the activity of the lambda phosphatase. There are a variety of phosphatases one may use to dephosphorylate proteins; the ones listed in this protocol are recommended examples. The end user is highly encouraged to optimize their chosen phosphatase(s) before determining phosphospecificity of an antibody.
In this protocol, we refer to the phosphatase treated section of membrane (Treated) and a non-treated section of membrane (Control).